2026 ACTA Trial of the Year Awards 2026 ACTA Trial of the Year Award Nominator details Please enter your personal details so that the ACTA team can contact you, if required, to confirm any of the details provided. Name * Name First Name First Name Last Name Last Name Email * Awards category I have read the award guidelines and believe this trial is eligible to be considered for (please tick all that apply) * ACTA Trial of the Year Award ONLY ACTA Trial of the Year Award AND ACTA STInG Excellence in Trial Statistics Award HEAT Excellence in Trial Based Health Economics Award ACTA Trial of the Year Award AND ACTA TRIPSIG Excellence in Implementation Science Award ACTA Consumer Involvement Award ONLY ACTA Clinical Quality Registry Award ONLY ACTA TRIPSIG Excellence in Implementation Science Award ONLY I wish to nominate a: * Clinical trial Registry Scientific name of the trial * Short name or acronym of the trial * ACTA member network or group that designed and led the trial. * Australasian Kidney Trials Network Australasian Leukaemia and Lymphoma Group Australasian Myeloma Research Consortium Australasian Nursing and Midwifery Clinical Trials Network Australasian Radiopharmaceutical Trials Network Australasian Society for Infectious Diseases Clinical Research Network Australasian Stroke Trials Network Australasian Type 1 Diabetes Immunotherapy Collaborative Australasian College for Emergency Medicine Clinical Trials Group Australia & New Zealand Gynaecological Oncology Group Australia and New Zealand Liver and Intestinal Transplant Registry Australia and New Zealand Musculoskeletal Clinical Trials Group Australia and New Zealand Sarcoma Association Limited Australia and New Zealand Society of Cardiac & Thoracic Surgeons National Cardiac Surgery Database Program Australian & New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Australian & New Zealand Neonatal Network Australian & New Zealand Urogenital & Prostate Cancer Trials Group Australian and New Zealand Alliance for Cardiovascular Trials Australian and New Zealand College of Anaesthetists Clinical Trials Network Australian and New Zealand Intensive Care Society Australian and New Zealand Transplant and Cellular Therapies Australian Orthopaedic Association National Joint Replacement Register Breast Cancer Trials Cancer Trials Australia Centre for Biostatistics and Clinical Trials Cerulea Clinical Trials – Centre For Eye Research Australia Children’s Inpatient Research Collaboration of Australia and New Zealand Clinical Hub for Interventional Research Collaborative Hyperbaric Medicine and Extreme Environment Research Association Network Cooperative Trials Group for Neuro-Oncology Curtin Centre for Clinical Research and Education GenesisCare Site Research Organisation GI Cancer Trials Gold Coast Hospital and Health Service Growing Minds Australia Icon Institute of Innovation and Research IMPACT TRIALS, School of Medicine, Deakin University Interdisciplinary Maternal Perinatal Australasian Collaborative Trials Network Kids Cancer Centre, Sydney Children’s Hospital Mater Misericordiae Health Services Brisbane Limited Melanoma and Skin Cancer Trials Limited Melanoma Institute Australia Melbourne Children’s Trials Centre Mental Health Australia Adult General Clinical Trials Network (MAGNET), Deakin University Menzies School of Health Research Methods and Implementation Support for Clinical and Health Research Monash University Clinical Trials Centre MQ Health MS Australia National Allergy Centre of Excellence National Endometriosis Clinical and Scientific Trials Network NHMRC Clinical Trials Centre NHMRC Synergy in Alcohol Treatment NSW Drug and Alcohol Clinical Research and Improvement Network Olivia Newton-John Cancer Research InstituteOMICO (Australian Genomic Cancer Medicine Centre) Paediatric Research in Emergency Departments International Collaborative Primary Care Collaborative Cancer Clinical Trials Group, University of Melbourne Prostate Cancer Outcomes Registry – Australia & New Zealand Psycho-oncology Co-operative Research Group Pulmonary Fibrosis Australasian Clinical Trials Queensland Centre for Mental Health Research Regional Trials Network – Victoria Save Sight Institute South Australian Health and Medical Research Institute St John of God Healthcare Inc Sydney Local Health District The George Institute for Global Health The PARTNER Network, University of Melbourne The Thoracic Society of Australia and New Zealand Thoracic Oncology Group of Australasia Trans Tasman Radiation Oncology Group (TROG Cancer Research) University of Queensland Clinical Trials Centre UNSW Medicine and Health, Clinical Research Unit Victorian Ambulance Cardiac Arrest Registry Victorian Cardiac Outcomes Registry Victorian Orthopaedic Trauma Outcomes Registry (VOTOR) and Victorian State Trauma Registry (VSTR) Wesley Research Institute Ltd If the trial was a collaboration between more than one group, please list below. Please upload a copy of the publication confirming the primary trial results Drop a file here or click to upload Choose File Maximum file size: 134.22MB ACTA Trial of the Year Award If you are submitting a nomination for this award, please ensure all required information is provided to allow your application to be fully assessed. Do you wish to nominate this trial for the Trial of the Year Award? Yes No, skip to nominate for another award Chief Investigator full name Chief Investigator email Chief Investigator contact number Please confirm that the trial meets the following eligibility criteria Collaboratively developed Multi-centre Investigator-driven Randomised controlled Primary results published (online or print) in 2025 Did this trial involve any commercial or industry collaboration? Yes No Please provide a brief summary, including details of any funding or in-kind support, involvement in the trial development, design, conduct and/or alalysis Peer Summary Please provide a brief summary (max 600 words) describing the trial and why it warrants recognition as the ACTA Trial of the Year. Please address each of the judging criteria below: The trial addressed a critical gap in the evidence or a significant innovation in healthcare delivery The quality of the research design, conduct and alanysis were outstanding There is a high likelihood that findings from the trial will significaltly impact clinical practice and policy and improve outcomes for patiends or healthcare delivery. You may include any relevant publications that support your nomination. Drop a file here or click to upload Choose File Maximum file size: 134.22MB Plain English summary Please provide a brief plain English summary (max 400 words) describing the trial and how the results are likely to impact patients and/or delivery of healthcare. This should be suitable for publication on the ACTA website and in the general media. ACTA STInG Excellence in Trial Statistics Award If you are submitting a nomination for this award, please ensure all required information is provided to allow your application to be fully assessed. Do you wish to nominate this trial for the ACTA STInG Excellence in Trial Statistics Award? Yes No, skip to nominate for another award Please confirm that the primary results of this trial were published (online or in print) in 2025. Yes Please confirm that the that the statistical analysis plan is publicly available. Yes Trial Chief Statistician name and statistician group / affiliation / organisation Trial Chief Statistician email Trial Chief Statistician contact number Statistical methods summary Please provide a brief summary (600 words max) describing the statisticall design and alaysis of this trial and why it warrants consideration for the ACTA STInG Excellence in Trial Statistics award. Please address each of the judging criteria below: The statistical aspects of trial design and planning (sample size, randomisation, analytical methods_ were of high quality, appropriate for the research question(s), and documented in a publically accessible statistical procedures The stastical analyses were executed as planned and, where not, deviations were transparent, of quality, and executed well following good stastistical procedures/practices. The reporting and interpretation of the statistical aspects of the trial were appropriate, transparent, and supporting by results from pre-specified analyses and/or well-defended departures from planned procedures following good statistical procedures/pratice. Please also include an overview of timelines (including dates of recruitment commencement and completion, dates of protocol versions and updates, dates of the statistical analysis plan including all versions and updates together with a changelog, dates of interim analyses (if relevant), date of database lock, and date of submission of the manuscript). In the case of multiple statistical analysis plans (e.g., publication, open repository, supplemental material), it must be indicated which plan should be considered as the final plan for evaluation by the Panel. Supplemental materials Please attach the final version of the supplemental materials listed below. Trial Protocol (for platform trials, please include the core protocol and any relevant domain specific appendix) Statistical Analysis Plan A timeline describing the date of the registration of the trial in trial registry, date first protocol approved, date first patient, date statistical analysis plan finalised and publicly available, date last patient recruited, date last patient last follow up, date of data lock, date analysis conducted, date of publication, Please ensure it is the final verson. Drop a file here or click to upload Choose File Maximum file size: 134.22MB ACTA Consumer Involvement Award If you are submitting a nomination for this award, please ensure all required information is provided to allow your application to be fully assessed. Do you wish to nominate this trial for the ACTA Consumer Involvement Award? Yes No, skip to nominate for another award Consumer Investigator / representative name Consumer investigaotor/representative email address (alternatively, please provide the name and email of a senior member of the study team) Consumer involvement value Describe the value to the study of consumer involvement in this clinical trial’s activities and why it warrants consideration for the ACTA Consumer Involvement Award (max 600 words). Examples may include experiential knowledge, which is often subjective or qualitative. Consider the criteria below: Consumers were significantly involved in protocol development or design activities Consumer involvement provided valuable and exceptional guidance to the proposed conduct of the trial You may include any relevant publications that support your nomination. Drop a file here or click to upload Choose File Maximum file size: 134.22MB Plain English summary Please provide a brief summary (400 words max) describing the benefit of consumer involvement in the trial, including, where appropriate, the consumer’s background and motivation for involvement. Plain English summaries should be suitable for publication on the ACTA website and in the general media. ACTA HEAT Excellence in Trial based Health Economics Award If you are submitting a nomination for this award, please ensure all required information is provided to allow your application to be fully assessed. Do you wish to nominate this trial for the ACTA HEAT Excellence in Trial Based Health Economics Award? Yes No, skip to nominate for another award Please confirm that the health economic analysis of this trial was published (online or in print) in 2025 Yes Lead Health Economist name and health economics group / affiliation / organisation Lead Health Economist email address Lead Health Economist contact number Peer summary Please describe the health economic analysis and why it warrants consideration for the ACTA-HEAT Excellence in Trial Based Health Economics Award (600 words maximum). Consider the criteria below: The health economics aspects of trial design and planning (e.g. collection and valuation of healthcare use data, patient-reported outcomes) were of high quality, and appropriate for the research question(s) The health economics analyses were executed as planned (e.g. as stated in the Health Economics Analysis Plan (HEAP) and, where not, deviations were transparent, of high quality, and well executed following best practices The reporting and interpretation of the health economic analyses and sensitivity analyses were appropriate, transparent, and supported by results The health economics analyses make a significant contribution to trials methodology, or health and social policy, or health impact. You may include any relevant publications that support your nomination. Drop a file here or click to upload Choose File Maximum file size: 134.22MB Plain English summary Please provide a plain English summary (400 words max) describing the health economic analysis and how the results are likely to impact patients and/or the delivery of healthcare. Plain English summaries should be suitable for publication on the ACTA website and in the general media. Please upload a copy of the Health Economics Analysis Plan (HEAP) and the economics analysis publication. Drop a file here or click to upload Choose File Maximum file size: 134.22MB ACTA Clinical Quality Registy Award If you are submitting a nomination for this award, please ensure all required information is provided to allow your application to be fully assessed. Do you wish to nominate this trial for the ACTA Clinical Quality Registry Award Yes No, skip to nominate for another award ACTA Member Registry Australia and New Zealand Liver and Intestinal Transplant Registry Australia and New Zealand Society of Cardiac & Thoracic Surgeons National Cardiac Surgery Database Program Australian & New Zealand Neonatal Network Australian and New Zealand Intensive Care Society Australian and New Zealand Transplant and Cellular Therapies Australian Orthopaedic Association National Joint Replacement Register Collaborative Hyperbaric Medicine and Extreme Environment Research Association Network ACTA Member Registry National Endometriosis Clinical and Scientific Trials Network Prostate Cancer Outcomes Registry – Australia & New Zealand Save Sight Institute The Thoracic Society of Australia and New Zealand Victorian Ambulance Cardiac Arrest Registry Victorian Cardiac Outcomes Registry Victorian Orthopaedic Trauma Outcomes Registry (VOTOR) and Victorian State Trauma Registry (VSTR) Executive Officer, Chairperson, Lead Investigator or equivalent name Executive Officer, Chairperson, Lead Investigator or equivalent email address Executive Officer, Chairperson, Lead Investigator or equivalent mobile phone number Peer summary Please provide a peer summary (600 words max) describing the registry and why it warrants consideration for the ACTA Clinical Quality Registry Award. Consider the criteria below: The governance of the registry: including demonstration of exceptional clinical and technical leadership, effective operational arrangements, the software and management systems in place, compliance with legislation and standards including participant identity controls and quality assurance processes Data quality: including the scope, scale and interoperability of the data, collection in alignment with core outcome sets and/or METEOR metadata standards (where defined), data linkage capacity and effective data analysis Impact: including reporting quality, engagement with relevant stakeholders and end-users of the data; relevant publications and the impact on health outcomes or services (annual reports may be attached as supporting evidence) Consumer involvement: inclusion of consumer representatives and/or advisory committees and the collection of PROMs and/or PREMs (where appropriate) Plain English summary Please provide a plain English summary (400 words max) describing the registry and how the results have, or are likely to, impact patients and/or the delivery of healthcare. Plain English summaries should be suitable for publication on the ACTA website and in the general media. Please provide a copy of any relevant supporting documentation, such as annual report/s and/or high-impact publications. A maximum of 3 documents will be considered by the judging panel Drop a file here or click to upload Choose File Maximum file size: 134.22MB ACTA TRIPSIG Excellence in Implementation Science Award Please complete each section of this nomination form. Do you wish to nominate this trial for the ACTA TRIPSIG Excellence in Implementation Science Award Yes No, skip to nominate for another award Please confirm that the primary results of this trial were published (online or in print) in 2025. Yes Lead Implementation Scientist name Lead Implementation Scientist email Lead Implementation Scientist contact number Chief Investigator name Implementation science methods summary Please provide a brief summary describing the implementation science design and analysis of this trial and why it warrants consideration for the ACTA TRIP SIG Excellence in Trial Implementation Science Award. In addition, please address each of the judging criteria: The implementation science components of trial design and planning (e.g. theories, models, frameworks, strategy or intervention, outcomes, analytical methods) were of high quality, appropriate for the research question(s), and documented in a publicly accessible location. The implementation analyses were executed as planned or – where not, deviations were transparent, of high quality, and executed well. The reporting and interpretation of the implementation science components of the trial were appropriate and transparent Brief plain language summary describing the implementation science strategy used and how the results are likely to impact patients and/or the delivery of healthcare (600 words max) Please upload a copy of the protocol, main results and any secondary publications reporting implementation research design and outcomes, and supplementary material is provided with this nomination form. Drop a file here or click to upload Choose File Maximum file size: 134.22MB You are now ready to submit your nomination. Please ensure that all relevant documents have been uploaded to this submission and that you have filled in all the relevant areas for your nominated awards. Please contact awards@acta.au should you have any questions. Submit If you are human, leave this field blank. Δ
